Description

Settlement calendar for acquisition window takeover of PHARMAIDS PHARMACEUTICALS LIMITED from August 4-18, 2025 with settlement on September 1, 2025.

Summary

BSE has announced the settlement schedule for the Offer to Buy – Acquisition Window (Takeover) for PHARMAIDS PHARMACEUTICALS LIMITED. The bidding period runs from August 4-18, 2025, with obligation download on August 29, 2025, and final settlement on September 1, 2025.

Key Points

  • Settlement Type: Takeover (Settlement No. 2025067)
  • Bid Period: August 4, 2025 to August 18, 2025
  • Demat shares must be delivered through Early Pay-in mechanism only
  • Market Type “(Takeover)” and settlement No. 2025067 to be used in depository systems
  • Early pay-in securities will be earmarked/blocked in client accounts
  • No EPN file upload required by members and custodians

Regulatory Changes

No new regulatory changes introduced. Process follows existing Revised Guidelines of Mechanism for acquisition of shares through Stock Exchange as per Notice No. 20200528-32 dated May 28, 2020.

Compliance Requirements

  • Members/Custodians must use Early Pay-in of Shares mechanism through both depositories
  • Must specify Market Type “(Takeover)” and settlement No. 2025067 in depository system
  • Early pay-in must be completed sufficiently in advance before BSE OTB bidding window closure
  • Members must refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges

Important Dates

  • Bid Start Date: August 4, 2025
  • Bid End Date: August 18, 2025
  • Obligation Download: August 29, 2025
  • Settlement Date: September 1, 2025

Impact Assessment

High impact for PHARMAIDS PHARMACEUTICALS LIMITED shareholders and trading members. The takeover offer provides an acquisition window for shareholders to tender their shares. Proper adherence to early pay-in procedures is critical for successful settlement. Members must ensure timely completion of depository processes to avoid settlement failures.

Impact Justification

Takeover offer with specific settlement procedures affecting shareholders of PHARMAIDS PHARMACEUTICALS LIMITED